SCHEMBL3127546

SCHEMBL3127546

COc1ccc(S(=O)(=O)C2CCN(c3nc(Cc4c(C)cccc4C)cs3)CC2)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.44
TSHR P16473 2/20 0.44
POLB P06746 1/20 0.44
KDM4E B2RXH2 2/20 0.39
MAPT P10636 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
TP53 P04637 2/20 0.36
HSD11B1 P28845 1/20 0.36
RECQL P46063 2/20 0.35
HTR7 P34969 1/20 0.35
NTSR1 P30989 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
USP2 O75604 2/20 0.35
HSD17B10 Q99714 2/20 0.35
LMNA P02545 2/20 0.35
F2RL3 Q96RI0 3/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3013286 0.93 KDM4E (0.39) HTTTSHRPOLBKDM4EMAPT
SCHEMBL3017841 0.91 POLB (0.42) HTTTSHRPOLBKDM4EMAPT
SCHEMBL3003521 0.90 TSHR (0.41) HTTTSHRPOLBKDM4EMAPT
SCHEMBL3005141 0.88 HTT (0.39) HTTTSHRPOLBKDM4EMAPT
SCHEMBL3009492 0.87 POLB (0.41) TSHRPOLBKDM4EMAPTSMN1; SMN2
SCHEMBL3014450 0.87 KDM4E (0.41) KDM4EMAPTSMN1; SMN2RAB9ANPC1
SCHEMBL3018931 0.87 KDM4E (0.39) HTTTSHRPOLBKDM4EMAPT
SCHEMBL3019256 0.86 TSHR (0.39) HTTTSHRPOLBKDM4EMAPT
SCHEMBL3002775 0.86 KDM4E (0.40) HTTTSHRPOLBKDM4EMAPT
SCHEMBL3012800 0.86 KDM4E (0.40) HTTTSHRPOLBKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722681-B2 N-sulfonyl thiazolylpiperazine derivatives and related N-sulfonyl heterocyclic derivatives for the treatment of neuro degenerative diseases NV REMYND (BE) 2014-05-13 US disclosed
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2010-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197703-A1 N-SULFONYL THIAZOLYLPIPERAZINE DERIVATIVES AND RELATED N-SULFONYL HETEROCYCLIC DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES SMN1; SMN2, HTT, SNCA HTT 2/4885TSHR 3320/4885POLB 4649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.